Sarah Doernberg MD
Assistant Professor, Medicine, University of California, San Francisco, School of
Join to View Full Profile
505 Parnassus AveSan Francisco, CA 94143
Phone+1 415-476-1528
Dr. Doernberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Infectious Disease, 2009 - 2011- University of California (San Francisco)Residency, Internal Medicine, 2006 - 2009
Yale School of MedicineClass of 2006
Certifications & Licensure
CA State Medical License 2008 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Olorofim Aspergillus Infection Study Start of enrollment: 2022 Mar 31
Roles: Contact
- Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial Start of enrollment: 2024 Feb 22
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Intention-to-diagnose and distinct research foci in diagnostic accuracy studies.Scott R Evans, Gene Pennello, Shanshan Zhang, Yixuan Li, Yike Wang
The Lancet. Infectious Diseases. 2025-03-27 - Taking the patient pulse: gauging outcomes important to patients for bloodstream infection trials.Sarah B Doernberg, Heather A King
Clinical Microbiology and Infection. 2025-02-20 - 1 citationsImpact of rapid antibiotic susceptibility testing for Gram-negative bacteremia varies by pathogen type and resistance: a secondary analysis of the RAPIDS GN trial.Ritu Banerjee, Abhigya Giri, Lauren Komarow, Maria Souli, Sarah B Doernberg
Microbiology Spectrum. 2025-02-04
Journal Articles
- Association of Race/Ethnicity with Likeliness of COVID-19 Vaccine Uptake Among Health Workers and the General Population in the San Francisco Bay AreaKevin Grumbach, Sarah B Doernberg, JAMA Internal Medicine
Press Mentions
As Big Pharma Loses Interest in New Antibiotics, Infections Are Only Growing StrongerJuly 15th, 2022- As Big Pharma Loses Interest in New Antibiotics, Infections Are Only Growing StrongerJuly 15th, 2022
- ‘Zero COVID Deaths’: Why Officials Are Pushing Paxlovid to Defang the CoronavirusMay 13th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
